Cliquer ici pour toutes les publications du CNR-MyRMA en 2010 / click here
1368488
{1368488:5KB9RK5J}
1
art-libraries-society-of-north-america-arlisna-reviews
50
default
799
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%225KB9RK5J%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222010-05-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26%23x201C%3BDetection%20by%20GenoType%20MTBDRsl%20Test%20of%20Complex%20Mechanisms%20of%20Resistance%20to%20Second-Line%20Drugs%20and%20Ethambutol%20in%20Multidrug-Resistant%20Mycobacterium%20Tuberculosis%20Complex%20Isolates%26%23x201D%3B%20by%20Florence%20Brossier%20et%20al.%20%26lt%3Bi%26gt%3BJournal%20of%20Clinical%20Microbiology%26lt%3B%5C%2Fi%26gt%3B.%2048%2C%20no.%205%20%28May%201%2C%202010%29.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01947-09%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01947-09%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Detection%20by%20GenoType%20MTBDRsl%20Test%20of%20Complex%20Mechanisms%20of%20Resistance%20to%20Second-Line%20Drugs%20and%20Ethambutol%20in%20Multidrug-Resistant%20Mycobacterium%20tuberculosis%20Complex%20Isolates%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22The%20GenoType%20MTBDRsl%20test%20rapidly%20detects%20resistance%20to%20ethambutol%2C%20fluoroquinolones%2C%20and%20second-line%20aminoglycosides%20%28amikacin%20and%20kanamycin%29%20and%20cyclic%20peptide%20%28capreomycin%29%20in%20Mycobacterium%20tuberculosis.%20A%20set%20of%2041%20multidrug-resistant%20%28MDR%29%20M.%20tuberculosis%20strains%2C%208%20extensively%20drug-resistant%20%28XDR%29%20M.%20tuberculosis%20strains%2C%20and%203%20non-MDR%20M.%20tuberculosis%20strains%20were%20tested%20by%20the%20MTBDRsl%20test%20and%20by%20DNA%20sequencing%20of%20the%20resistance-determining%20regions%20in%20gyrA%20and%20gyrB%20%28fluoroquinolones%20%5BFQ%5D%29%2C%20rpsL%20%28streptomycin%29%2C%20rrs%20and%20tlyA%20%28aminoglycosides%20and%5C%2For%20cyclic%20peptide%29%2C%20and%20embB%20%28ethambutol%29.%20The%20sensitivity%20and%20specificity%20of%20the%20MTBDRsl%20test%20were%20as%20follows%3A%2087%25%20and%2096%25%2C%20respectively%2C%20for%20fluoroquinolones%3B%20100%25%20for%20both%20for%20amikacin%3B%2077%25%20and%20100%25%2C%20respectively%2C%20for%20kanamycin%2C%2080%25%20and%2098%25%2C%20respectively%2C%20for%20capreomycin%3B%20and%2057%25%20and%2092%25%2C%20respectively%2C%20for%20ethambutol.%20Analysis%20of%20the%20discrepant%20results%20indicated%20that%20three%20FQ-resistant%20strains%20%28including%20one%20XDR%20strain%29%20with%20mutations%20in%20gyrB%20were%20missed%20by%20the%20MTBDRsl%20test%20and%20that%20one%20FQ-susceptible%20strain%2C%20identified%20as%20resistant%20by%20the%20MTBDRsl%20test%2C%20had%20a%20double%20mutation%20%28T80A-A90G%29%20in%20GyrA%20that%20did%20not%20confer%20resistance%20to%20FQ.%20Five%20strains%20%28including%20two%20XDR%20strains%29%20without%20mutations%20in%20rrs%20were%20monoresistant%20to%20aminoglycosides%20or%20cyclic%20peptide%20and%20were%20missed%20by%20the%20MTBDRsl%20test.%20Finally%2C%2012%5C%2F28%20ethambutol-resistant%20strains%20had%20no%20mutation%20at%20codon%20306%20in%20embB%2C%20while%202%5C%2F24%20ethambutol-susceptible%20strains%20had%20such%20a%20mutation.%20In%20conclusion%2C%20the%20MTBDRsl%20test%20efficiently%20detects%20the%20most%20common%20mutations%20involved%20in%20resistance%20to%20fluoroquinolones%2C%20aminoglycosides%5C%2Fcyclic%20peptide%2C%20and%20ethambutol%20and%20accurately%20assesses%20susceptibility%20to%20amikacin.%20However%2C%20due%20to%20mutations%20not%20included%20in%20the%20test%20%28particularly%20in%20gyrB%29%20or%20resistance%20mechanisms%20not%20yet%20characterized%20%28particularly%20those%20related%20to%20ethambutol%20resistance%20and%20to%20monoresistance%20to%20aminoglycosides%20or%20cyclic%20peptide%29%2C%20the%20wild-type%20results%20yielded%20by%20the%20MTBDRsl%20test%20should%20be%20confirmed%20by%20drug%20susceptibility%20testing.%22%2C%22date%22%3A%2205%5C%2F01%5C%2F2010%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.01947-09%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F48%5C%2F5%5C%2F1683%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222013-09-02T12%3A22%3A37Z%22%7D%7D%5D%7D
“Detection by GenoType MTBDRsl Test of Complex Mechanisms of Resistance to Second-Line Drugs and Ethambutol in Multidrug-Resistant Mycobacterium Tuberculosis Complex Isolates” by Florence Brossier et al. Journal of Clinical Microbiology. 48, no. 5 (May 1, 2010). https://doi.org/10.1128/JCM.01947-09.
